Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 22, 2017

DrugPatentWatch Database Preview

Digoxin - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for digoxin and what is the scope of digoxin patent protection?

is the generic ingredient in five branded drugs marketed by Hikma Intl Pharms, Concordia Pharms Inc, Hospira, Abraxis Pharm, Glaxosmithkline Llc, Covis Pharma Sarl, West-ward Pharms Int, Impax Labs, Sun Pharm Inds Inc, Stevens J, Sandoz Inc, Mylan Pharms Inc, Wyeth Ayerst, and Eurohlth Intl Sarl, and is included in sixteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for digoxin. Forty-one suppliers are listed for this compound.

Summary for Generic Name: digoxin

Drug Master File Entries: see list10
Suppliers / Packagers: see list41
Bulk Api Vendors: see list44
Clinical Trials: see list43
Patent Applications: see list8,022
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:digoxin at DailyMed

Pharmacology for Ingredient: digoxin

Ingredient-typeCardiac Glycosides
Drug ClassCardiac Glycoside
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline Llc
CAPSULE;ORAL018118-003Jul 26, 1982DISCNNoNo► Subscribe► Subscribe
INJECTABLE;INJECTION040206-001Aug 28, 1998DISCNNoNo► Subscribe► Subscribe
Concordia Pharms Inc
TABLET;ORAL020405-003Sep 30, 1997RXYesNo► Subscribe► Subscribe
Glaxosmithkline Llc
CAPSULE;ORAL018118-001Jul 26, 1982DISCNNoNo► Subscribe► Subscribe
Impax Labs
TABLET;ORAL078556-001Jul 20, 2009ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Identify first generic entrants
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus